Platelets undergo biochemical and morphologic changes when stimulated that greatly alter their function and contribute to their role in thrombosis and hemostasis. We recently identified and cloned the cDNAfor a platelet surface glycoprotein expressed on activated, not resting cells. We found that this protein, lysome-associated membrane protein-1 (LAMP-1). is an integral membrane protein of the lysosome that translocated to the surface membrane when platelets were stimulated by a strong agonist. We now show with immunofluorescence flow cytometry that LAMP-2, a lysosomal membrane protein that shares approximately 30% homology with LAMP-1, is also expressed preferentially on the surface of activated platelets. Equilibrium binding studies with lZ51-anti-LAMP-2 IgG showed approximately 1,100 binding sites per thrombin-stimulated platelet and less than 50 per resting LOOD PLATELETS normally circulate in a quiescent B state. However, when activated by a physiologic or pathologic agonist, their surface topography is altered and they participate in numerous surface-oriented reactions: they aggregate with one another; they adhere to other cells and surfaces; and they interact with enzymes and proenzymes of the coagulation,' fibrinolytic: contact; and complement sy~tems.~ Many of the structures that mediate these reactions remain undefined. To approach this question we have attempted to characterize proteins expressed on the surface of activated, but not resting platelets. Using the technique of expression cloning with epitope selection, we have recently identified and cloned a 110-Kd transmembrane glycoprotein present on the surface of activated, but not resting platelet^.^ This protein is identical to a recently identified protein isolated from lysosomal membranes of nucleated cells termed lysosome-associated membrane protein-1 (LAMP-l),6s7 and was shown to translocate from the lysosomal membrane to the plasma membrane when platelets were activated with strong agonists such as thrombin. Flow and fusion of platelet lysosomal membrane constituents suggest a novel mechanism of change of the platelet surface phenotype from a resting quiescent state to an activated, prothrombotic adhesive state. We now ask whether other lysosomal membrane proteins translocate to the surface after platelet activation. LAMP-1 is a member of a highly conserved small gene family made up of two
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It is approximately 30% homologous to another lysosomal membrane protein termed LAMP-2.7J2J3 Both proteins have the same general structure consisting of a short 10 to 11 amino acid carboy-terminal intracytoplasmic domain followed by a classic hydrophobic transmembrane region and then a large amino-terminal extracytoplasmic region. The latter consists of two homologous domains each made up of two 36 to 38 amino acid cystine-linked loops. These domains are separated by a pro-ser-rich region homologous to the hinge domain of IgA.14 The extracytoplasmic region has multiple sites for N-linked glycosylation, and contains greater than 60% carbohydrate by weight. Much of the carbohydrate consists of unusual polylactosaminoglycan residues.15 We now report that LAMP-2, like LAMP-1, is an activation-dependent platelet surface glycoprotein, and that surface expression results from lysosomal membrane flow and fusion.
MATERIALS AND METHODS

Materials.
Murine monoclonal anti-LAMP-2 (H4B4) and anti-LAMP-1 (H5Gll) antibodies and rabbit polyclonal anti-LAMP-2 and anti-LAMP-1 sera were gifts of Dr J.T. August (Johns Hopkins University, Baltimore, MD). These antibodies were generated from mice immunized from human LAMP proteins prepared from spleen extracts.13 An additional murine monoclonal anti-LAMP-2 IgG (CD3) was provided by M. Fukuda (La Jolla Cancer Center, La Jolla, CA).'J5 Monoclonal antiplatelet glycoprotein (GP) Ib (AP1) was from T. Kunicki (Blood Center of Southeast Wisconsin, Milwaukee) and anti-PADGEM (AC1.2) from Dr B. Furie (Tufts University Medical Center, Boston, MA). Murine antithrombospondin IgG 11.4 was prepared as previously described.I6 Rabbit polyclonal anti-p-galactosidase antibody was purchased from Cappel (Durham, NC). Fluorescein isothiocyanate (F1TC)-conjugated goat antirabbit and antimouse IgG were purchased from Tag0 (Burlingame, CA). Alkaline-phosphataseconjugated goat antirabbit and antimouse IgG were purchased from BioRad (Richmond, CA), as were the colorometric substrates, 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP) and p-nitro blue tetrazolium chloride (NBT). lZ5I-NaI (100 mCi/mL) and 5-hydroqfside ~hain-2-'~C]tryptamine (55 mCi1 Platelets were prepared from 20 mL fresh blood drawn in 2.7 mL acid citrate dextrose (38 mmol/Lcitric acid, 75 mmol/L sodium citrate, 136 mmol/L dextrose). After a lowspeed spin (20Og for 15 minutes), the top half of platelet-rich plasma was applied to a 25-cm column of Sepharose 2B preequilibrated with divalent cation-free Modified Tyrode's buffer (MTB 137 mmol/L NaC1, 0.475 mmol/L NaH2P04, 2.7 mmol/L KCI, 5 mmol/L HEPES, 1.2 mmol/L NaHC03, 5.5 mmol/L glucose, pH 7.4) containing 0.2% bovine serum albumin (BSA). The platelet peak was pooled and, in some cases, recalcified (to 1 mmol/ L) .
Immunofluorescence flow cytomeiry. Platelet aliquots were treated with agonists, or buffer control, for 3 minutes at 22T, followed, when appropriate, by the specific thrombin inhibitor, PPACK mol/L), for 2 minutes. Primary antibody was added for 30 minutes, followed by fixation in an equal volume of MTB containing 2.2% formaldehyde for 30 minutes. The platelets were washed three times with MTB/BSA and incubated with FITCconjugated second antibody for 30 minutes. After washing as before, the cells were resuspended in 400 pL filtered phosphatebuffered saline (PBS). Ten thousand cells were analyzed for each study, as previously described: using an Epics Flow Cytometer (Coulter, Hialeah, FL) gated to exclude nucleated cells.
Platelets were diluted and fixed in a solution of 1% paraformaldehyde in Hanks Buffered Salt Solution (HBSS) for 15 minutes. They were then adhered to polylysine-coated glass coverslips. The slides were divided into two groups: one group was incubated and washed in solutions of HBSS containing 0.1% saponin (for permeabilization), the other in solutions of HBSS alone. Slides were washed twice, incubated in 2% goat serum for 15 minutes, and then incubated with primary antibodies for 30 minutes. After extensive washing, slides were incubated with FITC-goat antimouse IgG for 30 minutes. Slides were washed again and viewed under fluorescence.
Platelets (lo8 cells) were lysed for 1 hour at 4°C in 150 mmol/L NaCl, 20 mmol/L Tris, pH 7.6,0.5% NP40, 1 mmol/L EDTA, 10 mmol/L sodium azide, 1 mmol/L phenylmethylsulfonyl fluoride (PMSF). The lysates were centrifuged at 12,OOOg for 10 minutes and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer was added to the supernatants. The samples were boiled, and l pL of the lysates was electrophoresed on a gradient (5% to 15%) polyacrylamide gel using the Phastgel system (Pharmacia). Proteins were transferred to nitrocellulose by capillary action,17 and the filters were incubated for 4 hours in a solution of TBS containing 0.05% Tween, and 5% instant nonfat dry milk (Carnation Co, Los Angeles, CA). Blots were then incubated in TBS/Tween containing rabbit anti-LAMP-2 IgG or nonimmune IgG for 18 hours at 4°C. After washing in TBS/Tween, they were incubated with alkalinephosphatase-conjugated goat antirabbit IgG for 20 minutes. The blots were washed and developed using the BCIP/NBT color development reagent system.18 '251-antibody binding studies. Murine monoclonal anti-LAMP-2 IgG was purified from ascites by chromatography on Staphalococcus protein A agarose (BioRad) and labeled with IZ5I using insolubilized chloramine-T (Iodobeads; Pierce Chemical Co, Rockford, IL). IZI-IgG binding was measured by incubating with 4 x lo7 gel-filtered platelets for 30 minutes at room temperature. The platelets were then layered over silicone oil and platelet-bound Platelet isolation.
Immunofluorescence microscopy.
Western blot.
radioactivity separated from free by centrifugation, as previously described.I6 For some studies, platelets were treated for 10 minutes before the addition of antibody with specific agonists (ADP, epinephrine, or thrombin), as above. Specific binding was quantified as that inhibited by a 20-fold excess of unlabeled antibody and was generally greater than 90%.
Serotonin release was measured by loading platelets with 14C-5-hydroxy tlyptamine for 10 minutes. After activation, platelets were pelleted by centrifugation and total, released, and cell-associated radioactivity were measured by scintillation counting? Released thrombospondin (TSP) was measured by double-sandwich enzyme-linked immunosorbent assay (ELISA).
Platelets were collected from fresh platelet-rich plasma, washed three times in Tris-citrate buffer (63 mmol/L Tris, pH 6.5,95 mmol/L NaCl, 5 mmol/L KCI, 12 mmol/L citric acid), and sonicated five times for 10 seconds at 4°C (Micro-ultrasonic cell disrupter, Kontes, Vineland, NJ; power setting 8). After brief centrifugation (5OOg for 5 minutes) the supernatant was layered over a gradient of 30% to 60% sucrose and centrifuged for 90 minutes at 217,OOOg at 4"C.19 In one experiment, platelets were loaded with ''C-hydroxtryptamine before sonication. Fractions were collected, diluted with 10% sucrose, and centrifuged for 15 minutes at 40,OOOg at 4°C. The granule-containing pellets were resuspended in 200 pL TBS, 0.5 mmol/L EDTA, pH 7.4, and then solubilized in 0.5% SDS or by freeze-thaw lysis. Protein concentrations were determined with the bicinchoninic acid (BCA) protein assay reagentZo (Pierce). I4C-hydroxytryptamine was detected by scintillation counting. Specific proteins were detected by ELISA. Two hundred fifty nanograms per fraction was coated in carbonate buffer onto each polystyrene microtitre well. After washing, specific monoclonal or polyclonal antibody was added, followed by an alkaline-phosphataseconjugated second antibody. The substrate, p-nitophenyl phosphate, was added and bound antibody detected as a function of color development at 405 nm.
Platelet mlease assays.
Sucrose densiv gradient fractionation. Fig 2) . These data suggest that LAMP-2, like LAMP-1, was translocated from internal platelet locations to the surface upon stimulation. Immunoblot analysis of platelet lysates (Fig 3) showed that LAMP-2 in these cells migrated as a broad band of approximately 110 to 120 Kd. This is similar to that reported for LAMP-2 purified from human liver. There was no reactivity with control nonimmune antibody.
RESULTS
Murine
To We have previously shown that, unlike a-granule and dense granule secretion, platelet lysosome release, measured as LAMP-l surface expression, did not follow stimulation by thc weak agonists ADP or epinephrine? In addition, platelet acid hydrolase release, which is presumably from lysosomes, has been studied by several investiga- tors and found to require strong agonist stimualtion.zl As shown in Fig 5, we found using indirect immunofluorescence flow cytometry that less than 10% of maximal thrombin-induced LAMP-2 expression was detected in response to platelet stimulation by high concentrations of the weak agonists ADP or epinephrine. These platelets secreted TSP (measured by ELISA) and expressed both surface TSP and P-selectin, indicating that both agonists induced activation and partial a-granule secretion (data not shown). These data show that LAMP-2 expression behaved like LAMP-1 expression5 and lysosomal secretionz1 and not like a-granule proteins in response to weak agonists. A series of sucrose density gradient platelet fractionation studies was perfofmed to investigate further the intracellular localization of LAMP-2 in resting platelets. Platelets were sonicated in such a way as to only disrupt their outer plasma membrane, and centrifuged through a 30% to 60% continuous sucrose gradient. A typical banding pattern was observed, as described previously.' Two narrow, low density "membrane" bands (fractions 2 and 4) were clearly distinguished from an intermediate density band (fraction 6) and two high density bands (fractions 8 and 10). These bands were collected along with the intervening regions (fractions 1,3,5,7,9, and 11 through 13), and subjected to protein and ELISA analyses. In one experiment, platelets were loaded with 14C-hydroqtryptamine, and radioactivity in the fractions detected by scintillation counting. Figure 6A shows colocalization of P-galactosidase, a lysosomal enzyme, and LAMP-1, a lysosomal membrane protein, with LAMP-2 in fraction 6. GPlb, a marker of the external platelet plasma membrane, did not cosediment with LAMP-2 and was found in fraction 4. Figure 6B For personal use only. on September 24, 2017. by guest www.bloodjournal.org From marker. Greater than 47% of the total couhts recovered were found in one high-density fraction, fraction 10. Figure  6C shows the localization of the a-granule marker, TSP. Greater than 90% of the total TSP was found in fractions 9 and 10. This biochemical pattern of a-granule and dense granule contents is similar to that reported by others.22 From these data, colocalization of LAMP-2 with lysosomal proteins, and clear differentiation from the two other granule pools, we conclude that LAMP-2 is lysosomal in resting platelets.
DISCUSSION
Secretion from membrane-bound cellular storage pools in response to agonist stimulation is a general characteristic of many cells, including platelets. In his widely accepted membrane flow hypothesis, PaladeZ3 suggested that during secretion, granule integral membrane proteins become incorporated into the external plasma membrane. Studies of P-selectin (GMP140), a platelet a-granule integral membrane protein," provided evidence that a membrane fusion event does indeed occur during platelet activation and secretion.z The biologic importance of this mechanism of phenotypic surface transformation by the activated platelet was shown by the recent demonstration that P-selectin is a "receptor" on activated platelets that mediates adhesion to leukocyte^.^^.^^ We recently reported that LAMP-1, an integral lysosomal membrane protein, also translocates to the plasma membrane during an activation and secretion event, suggesting that lysosomal membrane fusion also occurs during platelet secretion. Nieuwenhuis et aiB have also reported that CD63, a 53-Kd platelet activation antigen, is also a transmembrane lysosomal protein. Data reported here using highly specific monoclonal antibodies suggest that lysosomal membrane flow and fusion also leads to surface expression of a second, highly glycosylated protein, LAMP-2. However, the number of LAMP-1 and LAMP-2 molecules estimated on the surface of activated platelets ( < 2,000 of each) is substantially less than that reported for P-selectin or CD63. However, these data confirm the existence of lysosomal membrane fusion during platelet activation and identify another activaticin-dependent surface protein that may have a functional role during thrombosis.
These data also support the concept that platelet stimulation by "strong agonists" such as thrombin and collagen is mediated by different intracellular events than stimulation by "weak agonists" such as ADP and epinephrine. We previously showed that surface expression of LAMP-1 required platelet stimulation by a strong agonist? We have now studied LAMP-2 surface expression in response to different agonists and found expression was also maximal in response to thrombin and nearly absent on platelets stimulated with high concentrations of the weak agonists ADP or epinephrine. a-Granule secretion occurred under these circumstances, suggesting that lysosome secretion and membrane flow is coupled to a different stimulus-response pathway than a-granule secretion.
While there is no known function for either of the LAMP proteins, the amino acid sequence of LAMP-1 is nearly identical to two leukemia cell glycoproteins: GP130/P2B, from the highly metastatic tumor cell line MDAY-D2,6 and a differentiation marker in hematopoietic cells.29 In addition, the N-linked polylactosaminogylcans carried on both lysosomal proteins have been correlated with increased metastatic potential. 30 The sialylated polylactosamines carried by LAMP-1 and LAMP-2 are also potential substrates for a(1-3) fucosylation, leading to the generation of sialylated Lewisx (sLex) structure^.^^ Recent reports have shown that the sLex antigens are ligands for some members of the selectin adhesion molecule family (E-selectin and the L-selectin antigen).32-34 Although a minor fraction ( < 2%) of LAMP protein is associated with the plasma membrane of most nucleated ~e l l s , 3~
presumably as a result of selective exchange of lysosomal and plasma membranes, our studies are the first to show significant and regulated cell surface expression on normal adult cells. As previously noted, increased surface expression of LAMP has been observed on transformed cells of high metastatic potential and, interestingly, on embryonic Activated platelet surfaces share certain functional characteristics with these cells, such as enhanced adhesiveness and protease activity. It is thus possible that the regulated expression of LAMP-1 and LAMP-2 on the surfkice of activated platelets may play a role in these functions. A deglycosylated form of LAMP has been shown to bind collagen and the fibronectin adhesion peptide RGD,37 further suggesting a possible role in adhesion.
In summary, we report the identification and characterization of a previously unknown platelet activation marker. This protein translocates from the lysosomal membrane, and has characteristics of an adhesive molecule. Identification of proteins, like LAMP-1 and LAMP-2, that are preferentially expressed on activated cells may aid in the design of novel diagnostic and therapeutic approaches to diseases such as atherosclerosis and thrombosis.
